再生障碍性贫血免疫发病机制及免疫治疗

[1] Hematopoietic stem cells in aplastic a-nemia. Maciejewski JP,Risitano A. Archives of Medical Research . 2003

[2] HLA-DR4-Ala74β is associated with risk and poor outcome of severe aplastic anemia[J] . S. I. Kapustin,T. I. Popova,A. A. Lyshchov,E. N. Imyanitov,M. N. Blinov,K. M. Abdulkadyrov. &nbspAnnals of Hematology . 2001 (2)

[3] Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia [J]. ANNALS OF HEMATOLOGY, 2002, 81 (10) : 566 - 569

[4] Telomere length cariation and telomerase activity expression in patients with congenital and acquired aplastic anemia. Sophia P,Paraskevi K. Acta Haematologica . 2004

[5] Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow Tlympho-cytes from paediatric patients with aplastic anaemia. Dufour C,Corcione A,Svahn J,et al. British Journal of Haematology . 2001

[6] In vitro production of IFN-gamma correlates with CArepeat polymorphismin the human IFN-gamma gene. Pravica V,Asderakis A,Perrey C,et al. European Journal of Immunogenetics . 1999

[7] Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Fogarty PF,Yamaguchi H,Wiestner A,et al. The Lancet . 2003

[8] Aplastic anemia is associated with HLA-DRB1*1501in northern Han Chinese. Shao W,Tian D,Liu C,et al. International Journal of Hematology . 2000

[9] Glutathione S transferase theta1gene(GSTT1)null genotype is associated with an increased risk for acquired aplastic anemia in children. Dirksen U,Moghadam KA,Mambetova C,et al. Pediatric Research . 2004

[10] Homozygosis for(12)CA re-peats in the first intron of the human IFN-gamma gene is signifi-cantly associated with the risk of aplastic anaemia in caucasian pop-ulation. Dufour C,Capasso M,Svahn J,et al. British Journal of Haematology . 2004

[1] Hematopoietic stem cells in aplastic a-nemia. Maciejewski JP,Risitano A. Archives of Medical Research . 2003

[2] HLA-DR4-Ala74β is associated with risk and poor outcome of severe aplastic anemia[J] . S. I. Kapustin,T. I. Popova,A. A. Lyshchov,E. N. Imyanitov,M. N. Blinov,K. M. Abdulkadyrov. &nbspAnnals of Hematology . 2001 (2)

[3] Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia [J]. ANNALS OF HEMATOLOGY, 2002, 81 (10) : 566 - 569

[4] Telomere length cariation and telomerase activity expression in patients with congenital and acquired aplastic anemia. Sophia P,Paraskevi K. Acta Haematologica . 2004

[5] Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow Tlympho-cytes from paediatric patients with aplastic anaemia. Dufour C,Corcione A,Svahn J,et al. British Journal of Haematology . 2001

[6] In vitro production of IFN-gamma correlates with CArepeat polymorphismin the human IFN-gamma gene. Pravica V,Asderakis A,Perrey C,et al. European Journal of Immunogenetics . 1999

[7] Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Fogarty PF,Yamaguchi H,Wiestner A,et al. The Lancet . 2003

[8] Aplastic anemia is associated with HLA-DRB1*1501in northern Han Chinese. Shao W,Tian D,Liu C,et al. International Journal of Hematology . 2000

[9] Glutathione S transferase theta1gene(GSTT1)null genotype is associated with an increased risk for acquired aplastic anemia in children. Dirksen U,Moghadam KA,Mambetova C,et al. Pediatric Research . 2004

[10] Homozygosis for(12)CA re-peats in the first intron of the human IFN-gamma gene is signifi-cantly associated with the risk of aplastic anaemia in caucasian pop-ulation. Dufour C,Capasso M,Svahn J,et al. British Journal of Haematology . 2004